These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 9850093

  • 21. Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma.
    Masuda M, Ruan HY, Ito A, Nakashima T, Toh S, Wakasaki T, Yasumatsu R, Kutratomi Y, Komune S, Weinstein IB.
    Oral Oncol; 2007 Sep; 43(8):785-90. PubMed ID: 17169602
    [Abstract] [Full Text] [Related]

  • 22. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW, Li D, McQuone SJ, Ralston R.
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [Abstract] [Full Text] [Related]

  • 23. Anti-tumor effects of bevacizumab in combination with paclitaxel on head and neck squamous cell carcinoma.
    Fujita K, Sano D, Kimura M, Yamashita Y, Kawakami M, Ishiguro Y, Nishimura G, Matsuda H, Tsukuda M.
    Oncol Rep; 2007 Jul; 18(1):47-51. PubMed ID: 17549344
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP.
    Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
    [Abstract] [Full Text] [Related]

  • 25. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
    Hong YK, Chung DS, Joe YA, Yang YJ, Kim KM, Park YS, Yung WK, Kang JK.
    Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
    [Abstract] [Full Text] [Related]

  • 26. Interaction of retinoic acid and interferon-alpha in breast cancer cell lines.
    Widschwendter M, Daxenbichler G, Bachmair F, Müller E, Zeimet AG, Windbichler G, Uhl-Steidl M, Lang T, Marth C.
    Anticancer Res; 1996 Aug; 16(1):369-74. PubMed ID: 8615638
    [Abstract] [Full Text] [Related]

  • 27. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
    Nör JE, Christensen J, Liu J, Peters M, Mooney DJ, Strieter RM, Polverini PJ.
    Cancer Res; 2001 Mar 01; 61(5):2183-8. PubMed ID: 11280784
    [Abstract] [Full Text] [Related]

  • 28. Interferon-alpha in combination with chemotherapy has potent antiangiogenic properties in an orthotopic mouse model for pancreatic adenocarcinoma.
    Zhu Y, Tibensky I, Schmidt J, Hackert T, Ryschich E, Jäger D, Büchler MW, Märten A.
    J Immunother; 2008 Jan 01; 31(1):28-33. PubMed ID: 18157009
    [Abstract] [Full Text] [Related]

  • 29. Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma.
    Liss C, Fekete MJ, Hasina R, Lingen MW.
    Int J Cancer; 2002 Jul 20; 100(3):283-9. PubMed ID: 12115542
    [Abstract] [Full Text] [Related]

  • 30. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
    Lindner DJ, Borden EC, Kalvakolanu DV.
    Clin Cancer Res; 1997 Jun 20; 3(6):931-7. PubMed ID: 9815768
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K, Brockmann MA, Eckerich C, Bohlen P, May C, Mangold U, Fillbrandt R, Westphal M.
    Clin Cancer Res; 2005 Jul 01; 11(13):4934-40. PubMed ID: 16000592
    [Abstract] [Full Text] [Related]

  • 32. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P, Allegrini PR, Brandt R, Brueggen J, Cozens R, Fabbro D, Grosios K, Lane HA, McSheehy P, Mestan J, Meyer T, Tang C, Wartmann M, Wood J, Caravatti G.
    Cancer Res; 2004 Jul 15; 64(14):4931-41. PubMed ID: 15256466
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101.
    Murakami K, Sakukawa R, Sano M, Hashimoto A, Shibata J, Yamada Y, Saiki I.
    Clin Cancer Res; 1999 Sep 15; 5(9):2304-10. PubMed ID: 10499597
    [Abstract] [Full Text] [Related]

  • 34. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
    Drevs J, Fakler J, Eisele S, Medinger M, Bing G, Esser N, Marmé D, Unger C.
    Anticancer Res; 2004 Sep 15; 24(3a):1759-63. PubMed ID: 15274352
    [Abstract] [Full Text] [Related]

  • 35. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
    Zhang L, Yu D, Hicklin DJ, Hannay JA, Ellis LM, Pollock RE.
    Cancer Res; 2002 Apr 01; 62(7):2034-42. PubMed ID: 11929822
    [Abstract] [Full Text] [Related]

  • 36. Antitumor and antiangiogenic effects of interleukin 12 gene therapy in murine head and neck carcinoma model.
    Imagawa Y, Satake K, Kato Y, Tahara H, Tsukuda M.
    Auris Nasus Larynx; 2004 Sep 01; 31(3):239-45. PubMed ID: 15364358
    [Abstract] [Full Text] [Related]

  • 37. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y, Mazar AP, Lebrun JJ, Rabbani SA.
    Cancer Res; 2002 Aug 15; 62(16):4678-84. PubMed ID: 12183425
    [Abstract] [Full Text] [Related]

  • 38. Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats.
    Tei K, Kawakami-Kimura N, Taguchi O, Kumamoto K, Higashiyama S, Taniguchi N, Toda K, Kawata R, Hisa Y, Kannagi R.
    Cancer Res; 2002 Nov 01; 62(21):6289-96. PubMed ID: 12414659
    [Abstract] [Full Text] [Related]

  • 39. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
    Riedel F, Götte K, Li M, Hörmann K, Grandis JR.
    Int J Oncol; 2002 Jul 01; 21(1):11-6. PubMed ID: 12063543
    [Abstract] [Full Text] [Related]

  • 40. Antiangiogenic chemotherapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models.
    Schirner M, Hoffmann J, Menrad A, Schneider MR.
    Clin Cancer Res; 1998 May 01; 4(5):1331-6. PubMed ID: 9607594
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.